General
Australian AstraZeneca manufacturer CSL still committed to make 50 million vaccine doses
The Australian manufacturer of the AstraZeneca COVID-19 vaccine says it still plans to fill a federal government order of 50 million doses, despite health authorities recommending a different vaccine be preferred for those under 50 years of age.
Key points:
- CSL says it remains “committed to meeting its contracted arrangements” with the Australian government and AstraZeneca
- An expert panel has advised that the Pfizer vaccine is preferred for people under 50
- The federal government expects CSL will soon start producing one million AstraZeneca doses per week
On Thursday night, the panel of experts that advises the federal government on immunisation issues recommended that Pfizer be the preferred COVID-19 vaccine for adults under 50 due to the…
Continue Reading
-
Business19 hours agoIAG shares are racing higher today. Here’s why
-
General21 hours agoQueensland government dumps Forest Wind project
-
Business24 hours agoDid IDP Education shares just begin a major comeback?
-
Noosa News17 hours agoProp Allan Alaalatoa returns to the Wallabies line-up for Rugby Championship game against Argentina